Almoosa Health Co. (4018) is listed on Tadawul under the Health Care Equipment & Svc sector. In fiscal year 2025, the company reported revenue of SAR 1.42B, net profit of SAR 237M, and earnings per share of SAR 5.36. The stock trades at a P/E ratio of 29.0. All figures sourced from the official CMA-mandated XBRL filing dated 2025-12-31.
Almoosa Health Co. (4018) is listed on Tadawul of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).
For fiscal year 2025, Almoosa Health Co. reported revenue of SAR 1.42B, net profit of SAR 237M, and earnings per share of SAR 5.36. Total assets stood at SAR 3.31B with total equity of SAR 1.92B and total liabilities of SAR 1.39B.
Operating cash flow for 2025 was SAR 181M, representing a cash conversion ratio of 0.76 relative to net profit. Free cash flow was SAR -436M.
Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2025, SAR 0.76 arrived as operating cash. This indicates Moderate quality earnings based on the cash conversion ratio of 0.76.
Key financial ratios for 2025: Return on Equity 12.3%, Return on Assets 7.1%, Net Margin 16.7%, Debt to Equity 0.72.
Loading...